ELCC 2026: First-Line Immunotherapy in High PD-L1 Lung Cancer
/ Andreas Ravn Andersen
1. linje behandling ved EGFR-muteret NSCLC: effekt og bivirkninger
/ Jon Alexander Lykkegaard Andersen / Jan Andreasen
ELCC 2026: First-Line I-O Therapy Extends OS/PFS in Metastatic SCLC
/ Giuseppe Luigi Banna
Identifying Neurogenic Orthostatic Hypotension in Polyneuropathy
/ Markus Hedin Fedder
ELCC 2026: Blood-Based ML for Lung Cancer Prediction
/ Cecilie Mondrup Jacobsen











